@fluicell.com
Transforming how we treat diseases with high precsision tissue solutions. We are developing advanced human cardiac drug screening models and tissue-based type 1 diabetes therapeutics. 👉 https://www.fluicell.com/
Person dressed in blue lab clothes working in front of a microscope
Today on the World Cancer Day, we are highlighting the work of our partner Ambusol. Meet Ambusol's CEO Maximilian Telander and learn about their ambition to create new high precision therapeutics targeting gliblastoma.
👉 www.fluicell.com/news/changin...
The Cantu-syndrom H60Y mutation in the SUR2 subunit of ATP-sensitive potassium channels results in gain of function only when paired with Kir6.1. New Dynaflow publication in Journal of Biological Chemistry.
👉 www.jbc.org/article/S002...
@asbmbjournals.bsky.social #science #patchclamp #ionchannels
Big congratulations to Raquel Conde Holtzmann on receiving Second Prize in the ESPCI Alumni Internship Awards for her work with us on developing high throughput microfluidic cardiac screening platforms. It was a joy having you on our team and we are excited to follow you on your future journey.
Two researchers using a Biopixlar bioprinting system. Both researchers are looking at a computer monitor showing a microscopic view of cells being dispensed on a surface, while one of them uses a gamepad to control the instrument.
We installed a Biopixlar bioprinting system at @crick.ac.uk this week. Big thanks to amazing team at Making Lab for the smooth setup and warm welcome. Getting to see your facilities firsthand and hear about your research has been truly inspiring.
🧫 Read more about how Fluicell's microfluidic single-cell bioprinitng technology Biopixlar plays creates new opportunities for building high-fidelity models of early cancer development.
🔗 www.fluicell.com/news/a-bioen...
How can tissue engineering and biofabrication technologies advance cancer research? In a new review, Bertassoni and coworker explore how early cancer models facilitate a transition from treating to intercepting disease.
In recognition of the breast cancer awareness month, we are highlighting research that pave the way for new breast cancer treatments. Here, Trkulja et al present a method for designing antibodies for undruggable targets such as KRAS, whihch is implicated in TNBC.
www.science.org/doi/10.1126/...
“Some of my proudest moments as a researcher have been when I have been able to solve problems by going back to my notes to figure out the cause.”
👋 Meet Anton Rydberg and find out how applying a scientific mindset has value in both research and training.
🔗 www.fluicell.com/people/anton...
🧪 Want to combine bioprinitng and single-cell spatial transcriptomics? In a new paper in STAR Protocols, researchers at @ohsuknight.bsky.social present at method for spatial transcriptomics adapted for in vitro systems in 2D.
🔗 www.sciencedirect.com/science/arti...
🔬 Last week we had the great pleasure of opening a new part of our lab at Fluicell focused on extended tissue and cell culture studies. This new space further enhances our ability to analyze tissue development, cell function and cell survivability over time.
🔬 Last week we had the great pleasure of opening a new part of our lab at Fluicell focused on extended tissue and cell culture studies. This new space further enhances our ability to analyze tissue development, cell function and cell survivability over time.
👋Join us in welcoming Rosa Lacordaire and Charlotte Cany from @espciparispsl.bsky.social who are doing a research internship with us.
Supporting young researchers is an important part of Fluicell’s commitment to building the future of life science, and we’re excited to follow their progress.
We are excited to announce that we are partnering with Ambusol to create groundbreaking new ways to treat cancer. Leveraging our microfluidic technology, we are developing a novel type of device for high precision drug delivery directly to the tumor.
🔗 www.fluicell.com/news/fluicel...
A parent kissing a child. The child is looking slightly upwards and smiles. Text below the picture reads "Fluicell receives Breakthrough T1D project funding".
🚀 We are excited to announce that we have received funding from Breakthrough T1D for a collaboration to develop type 1 diabetes tissue therapeutics.
The collaboration combines our Nexocyte platfom with unique stem cell material to build designer islets for type 1 diabetes treatment.
Read more about the collaboration on Fluicell's website: www.fluicell.com/news/fluicel...
#Diabetes #CellTherapy #ATMP #Biofabrication
A parent kissing a child. The child is looking slightly upwards and smiles. Text below the picture reads "Fluicell receives Breakthrough T1D project funding".
🚀 We are excited to announce that we have received funding from Breakthrough T1D for a collaboration to develop type 1 diabetes tissue therapeutics.
The collaboration combines our Nexocyte platfom with unique stem cell material to build designer islets for type 1 diabetes treatment.
🧪 Researchers at @uofcalifornia.bsky.social have discovered new ways to selectively target specific voltage-gated sodium channels, affecting neuronal excitability. Their results can enable more precise ways to treat epilepsy and other neurological conditions.
🔗 www.fluicell.com/news/selecti...
🧪 Researchers at @uofcalifornia.bsky.social have discovered new ways to selectively target specific voltage-gated sodium channels, affecting neuronal excitability. Their results can enable more precise ways to treat epilepsy and other neurological conditions.
🔗 www.fluicell.com/news/selecti...
🧪Are you attending #AACR25? Make sure to check out the poster "Bioprinting 3D spatially resolved tumor avatars to mimic the native tumor microenvironment" presented by Haylie Helms of @ohsuknight.bsky.social (abstract nr LB161).
🔗 aacrjournals.org/cancerres/ar...
#CancerResearch #Bioprinting
A stunning example of biological complexity and the important relationship between tissue microstructure and function
🔗 Check out the BIRDIE website to learn more about the project: birdieproject.eu
Last week, the BIRDIE project organized a workshop to discuss how to bring in vitro research models from bench to business.
You can now watch a recorded version of the workshop, giving you the chance to learn more about organ-on-chip standardization, bioethics and in vitro model commercialization
🔗Read more about our Nexocyte platforom on our website: www.fluicell.com/platform
#Bioprinting #TissueEngingeering #RegenerativeMedicine
Microscope image of a bioprinted organoid. The image is partly covered by a white donut shape. Black text against a yellow background reads "Fluicell tissue technology patent granted in the EU".
We are excited to announce that our technology for generating three dimensional biological tissues has been granted a patent in the EU. The technology is the foundation for our tissue-based products for regenerative medicine and drug development targeting type 1-diabetes and cardiac disease.
Image of MDCK cell labeled using the light-activated photo-click adapters provided by Dr. Sarah Innes-Gold of Harvard University.
Microscope image showing cell fluorescently labeled in a crosshatch pattern. Text in the image reads "Publication spotlight: Tools for intersectional optical and chemical tagging on cell surfaces"
Can light be a tool for labeling living cells? In a new study from researchers at @harvard.edu and Chinese Academy of Medical Sciences, Sarah Innes-Gold et al. present a method for light-activated cell labeling with high precision. Read more on our website.
🔗 www.fluicell.com/news/scienti...
Owe Orwar and team have created a biohybrid random access memory based on patch-clamped GABA receptors placed in an open volume microfluidic device, generating laminar agonist patterns. The receptors read and store the chemical input signals as state distribution.
#JournalClub #Biohybrid #Dynaflow
Resolving GPCR-kinetics is key for understanding how external stimuli is converted to cellular response.
Using FRET, Carsten Hoffmann and team study how CXC chemokine receptor 4 ligands affect activation, revealing distinct mechanisms that reflect pharmacological properties.
#JournalClub
Resolving GPCR-kinetics is key for understanding how external stimuli is converted to cellular response.
Using FRET, Carsten Hoffmann and team study how CXC chemokine receptor 4 ligands affect activation, revealing distinct mechanisms that reflect pharmacological properties.
#JournalClub
At Fluicell, we have removed the need for bioinks altogether by building tissues directly in solution using open volume microfluidics. This lets us place cells close together with single-cell precision, enabling efficient intercellular communication.
Discover more on our website 👇